Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Pancreatic Adenocarcinoma · Stage III Pancreatic Cancer AJCC v8 · Stage IV Pancreatic Cancer AJCC v8 · Unresectable Pancreatic Ductal Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

City of Hope Medical Center, Duarte, California, United States
Contact: Study coordinator (Vincent Chung) · vchung@coh.org · 626-218-9200
Contact: Principal Investigator (Vincent Chung)

Study leads

Vincent Chung
Principal Investigator
City of Hope Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic · Cancer · Cancer of Pancreas

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Pancreatic Cancer · Locally Advanced Pancreatic Adenocarcinoma · Pancreatic Adenocarcinoma Non-resectable

Abroad (travel likely)Recruiting

Amsterdam, Netherlands

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Advanced Biliary Tract Carcinoma · Advanced Colorectal Carcinoma · Advanced Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Chicago, United States

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NSCLC Adenocarcinoma · Gastroesophageal Cancer (GC) · Gastric Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Santa Rosa, United States · Washington D.C., United States